RANKINGS

POPULAR STOCKS

Bruker Corporation

NasdaqGS:BRKR

Location

United States

Market Cap

USD 5.92 B

Share Price

USD 37.62

Avg Daily Volume

2,428,736

Change (1 day)

-3.74%

Change (1 year)

-41.99%

Change (YTD)

-35.82%

Bruker Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 3.45 B

Bruker Corporation Revenue is USD 3.45 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 14.84% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Bruker Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.00 B, a 14.49% change year over year.
  • Bruker Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.62 B, a 6.62% change year over year.
  • Bruker Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.46 B, a 16.05% change year over year.
  • Bruker Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.12 B, a 4.08% change year over year.
Key data
Date Revenue Revenue Gross Profit Operating Income
Market news
NasdaqGS: BRKR

Bruker Corporation

CEO Dr. Frank H. Laukien Ph.D.
IPO Date Aug. 4, 2000
Location United States
Headquarters 40 Manning Road
Employees 11,396
Sector 🏥 Health Care
Industries
Medical Instruments
🧬 Biotechnology
🔬 Chemicals & Advanced Materials
🔬 Clinical Trials
Description

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Similar companies

DHR

Danaher Corporation

USD 195.75

-2.67%

A

Agilent Technologies, Inc.

USD 116.09

-2.46%

600010.SS

Inner Mongolia Baotou Steel Union Co., Ltd.

USD 0.25

-0.61%

QGEN

Qiagen N.V.

USD 46.55

-1.90%

TECH

Bio-Techne Corporation

USD 49.50

-4.13%

TECN.SW

Tecan Group AG

USD 198.62

-1.34%

688068.SS

Beijing Hotgen Biotech Co., Ltd.

USD 19.29

-7.29%

688289.SS

Sansure Biotech Inc.

USD 2.81

-0.36%

EUZ.DE

Eckert & Ziegler Strahlen- und Medizintechnik AG

USD 74.39

-2.28%

RO.SW

Roche Holding AG

USD 340.74

-0.81%

ABT

Abbott Laboratories

USD 132.28

-1.29%

TMO

Thermo Fisher Scientific Inc.

USD 390.26

-3.66%

BSX

Boston Scientific Corporation

USD 101.73

0.24%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 50.33

-0.98%

SHL.DE

Siemens Healthineers AG

USD 52.66

-1.06%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 128.68

-2.90%

BDX

Becton, Dickinson and Company

USD 169.94

-1.26%

GEHC

GE HealthCare Technologies Inc.

USD 71.14

-2.36%

4543.T

Terumo Corporation

USD 18.14

1.81%

4901.T

FUJIFILM Holdings Corporation

USD 21.66

1.16%

DIM.PA

Sartorius Stedim Biotech S.A.

USD 227.06

-3.90%

NTRA

Natera, Inc.

USD 167.55

-0.42%

LH

Laboratory Corporation of America Holdings

USD 259.45

-1.71%

WAT

Waters Corporation

USD 341.10

-1.93%

BIM.PA

bioMérieux S.A.

USD 137.18

-1.76%

HLMA.L

Halma plc

USD 42.06

-1.66%

WST

West Pharmaceutical Services, Inc.

USD 218.06

-2.78%

BAX

Baxter International Inc.

USD 29.92

-2.92%

IEX

IDEX Corporation

USD 175.99

-2.18%

SN.L

Smith & Nephew plc

USD 14.48

-1.42%

RVTY

Revvity, Inc.

USD 94.16

-2.27%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.93

0.69%

6869.T

Sysmex Corporation

USD 17.05

0.62%

EXAS

Exact Sciences Corporation

USD 52.54

-1.43%

AVTR

Avantor, Inc.

USD 13.15

-2.08%

CTEC.L

ConvaTec Group Plc

USD 3.84

-1.65%

GMED

Globus Medical, Inc.

USD 58.14

-1.22%

AUROPHARMA.NS

Aurobindo Pharma Limited

USD 12.97

1.12%

4188.T

Mitsubishi Chemical Group Corporation

USD 5.24

-0.04%

7701.T

Shimadzu Corporation

USD 25.02

0.02%

RGEN

Repligen Corporation

USD 121.01

-4.03%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.01

-1.18%

BIO

Bio-Rad Laboratories, Inc.

USD 230.46

-0.53%

DIA.MI

DiaSorin S.p.A.

USD 107.26

-1.26%

000100.KS

Yuhan Corporation

USD 75.80

0.55%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.78

-0.63%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 2.01

-1.59%

688617.SS

APT Medical Inc.

USD 56.50

0.76%

LNTH

Lantheus Holdings, Inc.

USD 77.92

0.13%

SFZN.SW

Siegfried Holding AG

USD 114.36

-0.24%

StockViz Staff

June 18, 2025

Any question? Send us an email